Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Purple Biotech (PPBT) Net Income towards Common Stockholders (2016 - 2025)

Purple Biotech has reported Net Income towards Common Stockholders over the past 6 years, most recently at -$37.3 million for Q4 2022.

  • Quarterly Net Income towards Common Stockholders fell 836.24% to -$37.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$21.7 million through Dec 2022, down 217.84% year-over-year, with the annual reading at -$26.4 million for FY2025, 264.45% down from the prior year.
  • Net Income towards Common Stockholders was -$37.3 million for Q4 2022 at Purple Biotech, down from $4.8 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $7.3 million in Q1 2022 and troughed at -$37.3 million in Q4 2022.
  • The 5-year median for Net Income towards Common Stockholders is $3.6 million (2022), against an average of $51272.7.
  • Year-over-year, Net Income towards Common Stockholders skyrocketed 2205.45% in 2021 and then tumbled 836.24% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $349000.0 in 2018, then surged by 838.4% to $3.3 million in 2019, then tumbled by 93.28% to $220000.0 in 2020, then skyrocketed by 2205.45% to $5.1 million in 2021, then tumbled by 836.24% to -$37.3 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Net Income towards Common Stockholders are -$37.3 million (Q4 2022), $4.8 million (Q3 2022), and $3.6 million (Q2 2022).